Literature DB >> 7523213

Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation.

K L Davenpeck1, T W Gauthier, A M Lefer.   

Abstract

BACKGROUND/AIMS: Inhibition of nitric oxide synthesis increases leukocyte and endothelial interaction in mesenteric venules. In this study, the relationship between inhibition of NO and expression of the adhesion molecule P-selectin was examined.
METHODS: The rat mesentery was superfused with the NO inhibitor NG-nitro-L-arginine methyl ester (L-NAME) either alone or in combination with intravenous infusions of L-arginine, D-arginine, a P-selectin-neutralizing monoclonal antibody (PB1.3 [1 mg/kg]), recombinant human superoxide dismutase (hSOD), or 8 bromoguanosine 3',5'-cyclic monophosphate (8-br-cGMP). Leukocyte rolling and adherence were monitored in mesenteric venules via intravital microscopy. Ileal tissue superfused with L-NAME was examined immunohistochemically for P-selectin expression.
RESULTS: Superfusion of the rat mesentery with L-NAME resulted in a significant increase in leukocyte rolling and adherence in the mesenteric venule, which was attenuated by administration of L-arginine but not D-arginine. Monoclonal antibody PB1.3 as well as hSOD and 8-br-cGMP administered before initiation of L-NAME superfusion significantly attenuated the increase in leukocyte rolling and adherence. Immunohistochemistry showed a significant increase in P-selectin expression after 60 minutes of superfusion with L-NAME, which was attenuated by L-arginine, hSOD, and 8-br-cGMP.
CONCLUSIONS: These data indicate an important functional relationship between endothelial-derived NO production and expression of the endothelial adhesion molecule P-selectin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523213     DOI: 10.1016/0016-5085(94)90229-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  48 in total

Review 1.  Peroxynitrite and inflammatory bowel disease.

Authors:  D M McCafferty
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

2.  Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin.

Authors:  R Scalia; J Gefen; N A Petasis; C N Serhan; A M Lefer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats.

Authors:  D J Lefer; R Scalia; B Campbell; T Nossuli; R Hayward; M Salamon; J Grayson; A M Lefer
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

4.  Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions.

Authors:  D Fukumura; F Yuan; M Endo; R K Jain
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 5.  Gaseous Mediators in Gastrointestinal Mucosal Defense and Injury.

Authors:  John L Wallace; Angela Ianaro; Gilberto de Nucci
Journal:  Dig Dis Sci       Date:  2017-07-21       Impact factor: 3.199

Review 6.  cGMP modulation therapeutics for sickle cell disease.

Authors:  Nicola Conran; Lidiane Torres
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-28

7.  Angiotensin II is involved in nitric oxide synthase and cyclo-oxygenase inhibition-induced leukocyte-endothelial cell interactions in vivo.

Authors:  A Alvarez; L Piqueras; R Bello; A Canet; L Moreno; P Kubes; M J Sanz
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

8.  Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion.

Authors:  M Buerke; T Murohara; C Skurk; C Nuss; K Tomaselli; A M Lefer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

9.  S-nitroso human serum albumin given after LPS challenge reduces acute lung injury and prolongs survival in a rat model of endotoxemia.

Authors:  A Jakubowski; N Maksimovich; R Olszanecki; A Gebska; H Gasser; B K Podesser; S Hallström; S Chlopicki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

Review 10.  Nitric oxide in the gastrointestinal tract: opportunities for drug development.

Authors:  John L Wallace
Journal:  Br J Pharmacol       Date:  2018-12-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.